Impacts of the COVID‐19 pandemic on early detection of prostate cancer in Australia.
- Resource Type
- Article
- Authors
- Ip, Christopher C.K.; Kealey, Joshua; Davis, Ian D.; Sengupta, Shomik
- Source
- BJU International. Dec2021 Supplement S1, Vol. 128, p6-8. 3p.
- Subject
- *PROSTATE cancer
*EARLY detection of cancer
*FIDUCIAL markers (Imaging systems)
*COVID-19 pandemic
*PROSTATECTOMY
*RADICAL prostatectomy
- Language
- ISSN
- 1464-4096
Healthcare utilization has changed as a result of the COVID-19 pandemic. Analysis by age found that PSA tests for the age groups 45-54 and 55-64 years in 2020 declined to 91% and 94% of rates of PSA tests in 2018 and to 62% and 72% of rates of testing in 2012, respectively. JAMA 2018; 319: 1901 - 13 7 Prostate Cancer Foundation of Australia and Cancer Council Australia PSA Testing Guidelines Expert Advisory Panel Clinical practice guidelines PSA testing and early management of test-detected prostate cancer, 2015. [Extracted from the article]